Heme Once Flashcards
Primary Hemostasis
Injury to blood vessels causes platelet aggregation. Vasospasm, Adhesion, Activation, Aggregation
Vasospasm
Reflex neural vasospasm and also release of endothelin causes constriction of blood vessels
Adhesion
Collagen binds to vWF which is released from endothelial cells (WP bodies) and platelets (alpha granules). vWF binds to gp1b and activates platelet
Activation
Binding of Gp1b causes release of Ca and ADP from dense core granules. ADP activates the expression of gp2b3a (inhibited by clopidrogel, ticlopidine activation) which binds fibrinogen (released from alpha granules).
Aggregation
Platelets cross linked with fibrinogen and gp2b3a (gp2b3a blocked directly by abciximab). Release of COX activates TXA2 which promotes aggregation (aspirin irreveribly acetylates and deactivates COX)
Secondary Hemostasis
Clotting cascade ends with activation of factor 10 which activates factor 5 (cleaved by C, defect in factor V Lieden), which activates factor 2 (thombin) which cleaves fibrinogen to fibrin which is cross linked.
-Requires a phospholipid surface (platelets) and Ca
Intrinsic Pathway
12 to 11 to 9 (Hemophilia B) to 8 (hemophilia A, autoimmune to factor 8) to 10.
Followed with PTT
Heparin has more effect on Intrinsic Pathway
Extrinsic Pathway
7 to 10
Followed by PT (INR)
Warfarin Best Measurment
Kalikrein Pathway
HMWK cleaved by active factor 12. Leads to Kalikrein production
- Kalikrein activates Plasminogen to plasmin which cleaves fibrin and fibrinogen and prevents platelet aggregation
- Kalikrein also activates Bradykinin responsible for vasodilation, pain, permiability
- Plasmin activates C3 to begin complement cascade
Vitamin K Factors
2,7,9,10,C,S.
Warfarin induced skin necrosis because C has shorter halflife. Give heparin during initial warfarin dose
Protein C
Activated by protein S and Cleaves Factor 5.
-Factor 5 Lieden
Endothelial Derived anticoagulant Factors
NO, PGI2, Thrombomodulin
Thrombomodulin
Turns thombin into protein C activator (anti coagulant)
Hemophilia A
XR, can be de novo
Defect in Factor 8. Impaired extrinsic cascade, elevated PTT normal PT and bleeding time
Will improve with mixing studies
-Bleeding into joints, easy brusing, rebleed following surgery (tooth extraction)
Coagulation Factor inhibitor
Autoimmune to Factor 8
Same presentation with bleeding into joints, increased PTT
Does not improve with mixing studies
Hemophilia B
Same presetation as A except there will be an absence of factor 9
ITP
- Autoimmune, IgG Ab to platelet produced in spleen. Platelets removed by splenic macrophages.
- Increased bleeding time with normal PT and PTT, -Decreased platelet count and increased megakaryocytes in BM
- Clinically epistaxis, menorhaggia, increased skin and mucosal bleeding.
- Acute: Most commonly in kids, manage symptomatically and with steroids, generally resolves
- Chronic: Seen more in adult women of childbearing age, treat chronically with steroids
- IVIG can also be used to treat.
- IgG can be passed to fetus through placenta
- Splenectomy is curative in refractory cases.
TTP (Thrombotic Thrombocytopenic Purpura)
- Decreased ADAMSTS13 (most commonly autoAb to ADAMSTS13)
- Normally ADAMSTS13 cleaves vWF multimers into monomers for rapid degredation. Loss of ADAMSTS13 prevents cleavage and leads to activtion of coagulation cascade
- Formation of Microthrombi, Consumption of platelets, microangiopathic hemolytic anemia.
- Increased bleeding time with normal PT and PTT
- Also more commonly causes neurologic signs and fever. May also cause renal failure, but more common in HUS.
- Tx: Plasmaphoresis and immunosuppressives
HUS
- Following infection with E Coli O157:H7 (bloody diahrrea from undercooked meat)
- Release of verotoxin which inhibits protein synthesis (23s/60s)
- Microangiopathic hemolytic anemia at kidney
- Also causes fever and renal failure. Less commonly causes neurologic signs (more likely TTP)
Bernard Soulier
Defect in gp1b prevents adhesion of collagen to vWF to platelets
-Large platelets with defects in primary hemostasis
Decreased platelet number and increased bleeding time
-Increased mucosal bleeding, menorrhagia and epistaxis
Glanzmans
Defect in gp2b3a prevents primary hemostasis
- Increased bleeding time
- Increase in bleeding time with no decrease in platelets
ATIII Deficency
Lack of ATIII which normally inhibits all aspects of the coagulation cascade, will lead to hypercoagulability
-Treatment with normal dose heparin will be ineffective, must give higher dose.
Uremia
Impairs platelet aggregation and will lead to increased bleeding times
Factor V Lieden
Very Common
Prevents cleavage by protein C which makes it more active and increases coagulability